Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jeremy Curnock Cook
AddedFeb 19, 2024
UpdatedMay 31, 2026
Jeremy Curnock Cook

Jeremy Curnock Cook

Board Member, BioScience Managers

CrunchbaseLinkedIn

Jeremy Curnock Cook's Career

BioScience Managers
BioScience Managers

Melbourne, Victoria, AU

Board Member· Board
Excalibur Fund Managers
Excalibur Fund Managers

London, Greater London, GB

Board Member· Board
Arthurian Life Sciences
Arthurian Life Sciences

Cardiff, South Glamorgan, GB

Board Member· Board
AVITA Medical
AVITA Medical

Valencia, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jeremy Curnock Cook's Career

BioScience Managers
BioScience Managers
Investment FirmInvestment Firm302003Melbourne, Victoria, AU
Board Member· Board

Leadership at BioScience Managers

Nicole VitulloNicole VitulloBoard Member
Dennis PurcellDennis PurcellBoard Member
Matt McNamaraMatt McNamaraBoard Member
Alan CaineyAlan CaineyBoard Member
Jonathan BuckleyJonathan BuckleyCo-Founder
Jonathan HeppleJonathan HeppleCo-Founder
Excalibur Fund Managers
Excalibur Fund Managers
Investment FirmInvestment Firm51996London, Greater London, GB
Board Member· Board

Leadership at Excalibur Fund Managers

Chris EvansChris EvansBoard Member
Martin WaltonMartin WaltonCEO
Jeremy StoneJeremy StoneBoard Member

Similar to Excalibur Fund Managers

Excel Venture ManagementExcel Venture ManagementBoston, MA, USest. 2008Excel Venture ManagementBoston, MA, US · est. 2008

Excel Venture Management: A US-based venture capital firm investing in healthcare, IT, and life sciences.

Investment Firm13
Advent Life SciencesAdvent Life SciencesLondon, Greater London, GBest. 2006Advent Life SciencesLondon, Greater London, GB · est. 2006

Advent Life Sciences LLP, a UK-based venture capital firm, specializes in investments in life sciences.

Investment Firm31
Luminous VenturesLuminous VenturesLondon, Greater London, GBest. 2018Luminous VenturesLondon, Greater London, GB · est. 2018

Luminous Ventures: A London-based VC fund investing in Deep Tech across healthcare, life science, and agriculture sectors.

Investment Firm9
Expeditions FundExpeditions FundWarsaw, Masovian Voivodeship, PLest. 2021Expeditions FundWarsaw, Masovian Voivodeship, PL · est. 2021

Expeditions Fund is a global venture capital firm, investing in early-stage tech companies, backed by high-profile investors.

Investment Firm7
Arthurian Life Sciences
Arthurian Life Sciences
Investment FirmInvestment Firm302012Cardiff, South Glamorgan, GB
Board Member· Board

Leadership at Arthurian Life Sciences

John Michael BanhamJohn Michael BanhamBoard Member
Chris EvansChris EvansBoard Member
AVITA Medical
AVITA Medical
Public$300.4M1262020Valencia, CA, US
Board Member· Board

Leadership at AVITA Medical

Cary VanceCary VanceBoard Member
Fiona WoodFiona WoodFounder
Lou PanaccioLou PanaccioBoard Member
Jim CorbettJim CorbettBoard Member
Jan Stern ReedJan Stern ReedBoard Member

Similar to AVITA Medical

Aivita BiomedicalAivita BiomedicalIrvine, CA, USTherapies, Vaccinesest. 2016Aivita BiomedicalIrvine, CA, US · est. 2016

AIVITA Biomedical: Advancing curative and regenerative medicine programs.

Series A · $62.3M20
AvraAvraPalo Alto, CA, USAnti-Aging, Stem Cell Treatmentsest. 2010AvraPalo Alto, CA, US · est. 2010

Newregen Inc: A global biotech firm specializing in stem cell treatments and anti-aging solutions.

Seed · $150k6
Avacen MedicalAvacen MedicalSan Diego, CA, USMedical Devicesest. 2012Avacen MedicalSan Diego, CA, US · est. 2012

AVACEN offers non-invasive, painless treatments using cutting-edge technology to enhance body's thermal regulation.

Seed · $2M20
Avation MedicalAvation MedicalColumbus, OH, USHealthTech, Medical Devicesest. 2016Avation MedicalColumbus, OH, US · est. 2016

Avation Medical pioneers wearable nerve stimulation system platforms.

Series C · $34.9M125

Jeremy Curnock Cook's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · Dunamu

People Similar to Jeremy Curnock Cook

Kent HawrylukKent HawrylukBoard Member · GustoCory BerklandCory BerklandBoard Member · Orion BioScienceKfir MoyalKfir MoyalBoard Member · iAngels CrowdKevin ScanlonKevin ScanlonBoard Member · Pasadena AngelsMichael JonesMichael JonesBoard Member · Arrive